Tariff revenues will help narrow the US budget deficit in 2025, but the hit to economic growth and additional tax cuts are likely to limit the size of any lasting fiscal benefit, Fitch Ratings said in a report.
J&K CM Omar Abdullah stresses the need for zero tolerance towards terrorism, recalling the state's 2014 progress. He also criticized the US for imposing tariffs, comparing its trade stance to China's approach.
After staging a smart comeback yesterday, Indian stock markets ended on a negative note on Wednesday, showing no major enthusiasm for the policy interest cut by the Reserve Bank of India (RBI).
Speaking to ANI, NCP-SCP MP Supriya Sule said, "Tariffs was a challenge that was most expected. In all our budget speeches, we had all mentioned that the government needs to have a high-powered team and let's keep politics aside and get all the stakeholders involved. Justice delayed is justi
The Reserve Bank of India (RBI) will ensure swift transmission of repo rate cut benefits, says governor Sanjay Malhotra in a post-policy press conference.
Speaking after the All India Congress Committee (AICC) session in Gujarat, Congress MP Gurjeet Singh Aujla accused the government of ignoring pressing economic issues while pushing legislation like the Waqf Amendment Bill.
External Affairs Minister (EAM) S Jaishankar spoke about the impact of the recent set of tariffs introduced by the US on countries across the world. He saw a silver lining and said that this would further boost the trade talks in place with the US. Jaishankar made the remarks at the Risin
Karnataka Deputy CM DK Shivakumar on Wednesday said that Prime Minister Narendra Modi should take a clear stance on the recent stock market fluctuations, citing concerns about protecting Indian industries and investors.
India's real GDP is revised downwards to grow at 6.5 per cent in the current financial year 2025-26 from earlier expectation of 6.7 per cent, highlighted Reserve Bank of India (RBI) Governor Sanjay Malhotra during the policy announcement on Wednesday.
Indian generic drug manufacturers play a significant role in the U.S. healthcare system, supplying nearly 40 percent of the generic drugs imported into the country.